MLYS peer analysis
Mineralys Therapeutics (MLYS) against its competitors: price, today's move, 1-year return and market value side by side.
MLYS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DMAC DiaMedica Therapeutics | $9.34 | 3.32% | 35.94% | $580.78M |
| MAZE Maze Therapeutics | $34.69 | 6.64% | 7.47% | – |
| OBIO Orchestra BioMed | $5.58 | -0.71% | 43.37% | – |
| TVTX Travere Therapeutics | $49.00 | 0.27% | 44.93% | – |
| UNCY Unicycive Therapeutics | $3.46 | -0.72% | -24.02% | – |
| VERA Vera Therapeutics | $30.37 | 0.76% | 25.06% | – |
| MLYS Mineralys Therapeutics | $15.33 | 0.59% | -61.56% | – |
- MLYS's peers: DMAC (DiaMedica Therapeutics), MAZE (Maze Therapeutics), OBIO (Orchestra BioMed), TVTX (Travere Therapeutics), UNCY (Unicycive Therapeutics), VERA (Vera Therapeutics).
Updated 2026-11-07 11:53 UTC